Metis TechBio, IMPACT Therapeutics shine in Hong Kong debut

Metis TechBio

13/05/2026 05:17

** Metis TechBio 7666.HK jumps 144.8% from HK$10.50 offer price in Hong Kong debut, seventh most active stock by turnover

** AI-driven nanotech developer's shares earlier hit HK$29.98; Hang Seng .HSI gains 0.3%

** 74.6 mln shares worth HK$2.16 bln ($276 mln) traded so far

** Co raised HK$2.11 bln for R&D, clinical trials in global offering

** Hong Kong public offering portion was 6,910.96x subscribed, international portion is 33.86x subscribed

** IMPACT Therapeutics 7630.HK also debuts strong, up 111.9% from HK$20.10 offer price after 123.9% peak

** China biotech firm raised HK$844 mln for clinical development

** Hong Kong public offering portion was 2,282.4 times subscribed, international portion is 24.58 times

($1 = 7.8281 Hong Kong dollars)

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))